OFT study: ABPI statement

The Association of the British Pharmaceutical Industry (ABPI) has said that it will fully co-operate with the study announced by the Office of Fair Trading into the Pharmaceutical Price Regulation Scheme (PPRS).

Page Content

​The PPRS, which has been in existence in one form or another for nearly 50 years, has three main aims. They are to:

Secure the provision of safe and effective medicines for the NHS at reasonable price.

Promote a strong and profitable pharmaceutical industry capable of such sustained research and development expenditure as should lead to the future availability of new and improved medicines.

Encourage the efficient and competitive development and supply of medicines to pharmaceutical markets in this and other countries.

It achieves this by capping the profits that pharmaceutical companies can make on their sales of branded, prescription medicines to the NHS. It does not cover generic medicines.

“The PPRS is conducted in a very open and transparent way, with annual reports to Parliament about its progress and full details of how it operates made public,” said Dr Richard Barker, Director General of the ABPI.

“We shall of course co-operate fully with the OFT as requested by them during the course of their study.”

There is an ABPI publication, Understanding the PPRS, which explains how the scheme works. It is available through the ABPI website.

Get in touch

I am happy for ABPI to keep my details on file and to send me details of future ABPI work and services. ABPI will not sell your data to any third party or send you any information about products or services that ABPI has no direct connection with.

The Association of the British Pharmaceutical Industry

is a company limited by guarantee registered in England and Wales
(registered number 09826787) and its registered office is at
7th Floor Southside,105 Victoria Street, London, SW1E 6QT.
Telephone +44 (0) 207 9303477

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI. The PMCPA is a division of ABPI which is a company registered in England and Wales (registered number 09826787) with its registered office at 7th Floor, Southside, 105 Victoria Street, London SW1E 6QT.

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 7th Floor Southside, 105 Victoria Street, London, SW1E 6QT. OHE provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.